Company Registration No. 16270333 (England and Wales)
Charef Medical Ltd
Unaudited accounts
for the period from 24 February 2025 to 28 February 2026
Charef Medical Ltd
Unaudited accounts
Contents
Charef Medical Ltd
Company Information
for the period from 24 February 2025 to 28 February 2026
Directors
AL IDELBI, Zeina
RASLAN, Charef
Company Number
16270333 (England and Wales)
Registered Office
14 Longmeade Gardens
Wilmslow
Cheshire
SK9 1DA
England
Accountants
Rock Advisory Limited
13 Carrwood Road
Wilmslow
SK9 5DJ
Charef Medical Ltd
Statement of financial position
as at 28 February 2026
Cash at bank and in hand
30,436
Creditors: amounts falling due within one year
(31,458)
Net current liabilities
(1,022)
Profit and loss account
122
For the period ending 28 February 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 4 August 2026 and were signed on its behalf by
RASLAN, Charef
Director
Company Registration No. 16270333
Charef Medical Ltd
Notes to the Accounts
for the period from 24 February 2025 to 28 February 2026
Charef Medical Ltd is a private company, limited by shares, registered in England and Wales, registration number 16270333. The registered office is 14 Longmeade Gardens, Wilmslow, Cheshire, SK9 1DA, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Fixtures & fittings
25% RBM
Computer equipment
33% SLM
4
Tangible fixed assets
Fixtures & fittings
Computer equipment
Total
Cost or valuation
At cost
At cost
At 28 February 2026
288
1,099
1,387
Charge for the period
56
183
239
At 28 February 2026
56
183
239
At 28 February 2026
232
916
1,148
5
Creditors: amounts falling due within one year
2026
Taxes and social security
5,668
Loans from directors
24,170
Charef Medical Ltd
Notes to the Accounts
for the period from 24 February 2025 to 28 February 2026
6
Average number of employees
During the period the average number of employees was 1.